EU Preserves Status Quo On Drugs Under Additional Monitoring
Concerns Regarding Inconsistencies In Current Approach Are Noted
Executive Summary
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.